Table 1 Characteristics of the enrolled patients
From: Artificial intelligence driven 3D reconstruction for enhanced lung surgery planning
Variable | Total | Center 1 | Center 2 | Center 3 |
|---|---|---|---|---|
Number of cases, n | 140 | 60 | 40 | 40 |
Age, median (IQR), years | 58 (49, 65) | 60 (53, 65) | 56 (47, 65) | 52.5 (46, 65) |
Sex, n (%) | ||||
Female | 76 (54.3%) | 26 (43.3%) | 28 (70.0%) | 22 (55.0%) |
Male | 64 (45.7%) | 34 (56.7%) | 12 (30.0%) | 18 (45.0%) |
Tumor location | ||||
Right upper lobe | 49 (35.0%) | 20 (33.3%) | 14 (35.0%) | 15 (37.5%) |
Right middle lobe | 4 (2.9%) | 1 (1.7%) | 1 (2.5%) | 2 (5.0%) |
Right lower lobe | 24 (17.1%) | 15 (25.0%) | 5 (12.5%) | 4 (10.0%) |
Left upper lobe | 39 (27.9%) | 14 (23.3%) | 11 (27.5%) | 14 (35.0%) |
Left lower lobe | 24 (17.1%) | 10 (16.7%) | 9 (22.5%) | 5 (12.5%) |
Surgery type, n (%) | ||||
Segmentectomy | 78 (55.7%) | 34 (56.7%) | 18 (45.0%) | 26 (65.0%) |
Lobectomy | 62 (44.3%) | 26 (43.3%) | 22 (55.0%) | 14 (35.0%) |
Histology, n (%) | ||||
ADC | 83 (59.3%) | 46 (76.7%) | 18 (45.0%) | 19 (47.5%) |
MIA | 28 (20.0%) | 12 (20.0%) | 1 (2.5%) | 15 (37.5%) |
AIS | 12 (8.6%) | 1 (1.7%) | 10 (25.0%) | 1 (2.5%) |
SCC | 7 (5.0%) | 1 (1.7%) | 5 (12.5%) | 1 (2.5%) |
AAH | 2 (1.4%) | 0 | 1 (2.5%) | 1 (2.5%) |
LCNEC | 2 (1.4%) | 0 | 1 (2.5%) | 1 (2.5%) |
Metastatic | 1 (0.7%) | 0 | 1 (2.5%) | 0 |
Benign | 4 (2.9%) | 0 | 3 (7.5%) | 1 (2.5%) |
Others | 1 (0.7%) | 0 | 0 | 1 (2.5%) |
CT instrument manufacturer | ||||
GE | 45 (32.1%) | 12 (20.0%) | 33 (82.5%) | 0 |
Philips | 35 (25.0%) | 28 (46.7%) | 7 (17.5%) | 0 |
Siemens | 52 (37.1%) | 19 (31.7%) | 0 | 33 (82.5%) |
UIH | 8 (5.7%) | 1 (1.7%) | 0 | 7 (17.5%) |
Chest CT slice thickness, mm | ||||
1 | 92 (65.7%) | 47 (78.3%) | 7 (17.5%) | 38 (95.0%) |
1.25 | 13 (9.3%) | 13 (21.7%) | 0 | 0 |
0.7 | 2 (1.4%) | 0 | 0 | 2 (5.0%) |
0.625 | 33 (23.6%) | 0 | 33 (82.5%) | 0 |
